目錄:杭州斯達特生物科技有限公司>>抗體/抗原>>Biosimilar抗體>> S0B0565Anti-IL-17A Monoclonal Antibody(Ixekizumab)
Ixekizumab is an injectable medication for the treatment of autoimmune diseases. It is a form of a humanized monoclonal antibody. The substance acts by binding interleukin 17A and neutralizing it, reducing inflammation.